Learn how to select a winning IPO team in our latest eBook. Download Now

Westicke Partners

Close

Posts by Constantine Davides

Constantine Davides

Constantine Davides is a Managing Director on Westwicke's life sciences, healthcare services, and healthcare technology teams. He has extensive sell-side, buy-side, and industry experience. He has a BA from Wesleyan University and an MBA from Carnegie Mellon.

Planning a Life Sciences IPO in 2020? Considerations Ahead of an Election Year

Posted on May 22nd, 2019. Posted by

Planning a Life Sciences IPO in 2020

Comprised of former buy- and sell-side professionals, Westwicke’s managing directors can attest to how notoriously difficult financial markets are to predict. One area where there is at least some degree of certainty is the heightened challenge of executing a financing in the midst of an election year, where initial public offering (IPO) activity and appetite for risk tend to diminish, particularly in a politically-charged vertical such as healthcare.

Continue Reading

The Market for Life Sciences IPOs: Crunching the Numbers

Posted on June 27th, 2018. Posted by

Life Cycle IPOs

We are regularly asked to characterize the market backdrop for potential life sciences IPOs. While biotech ETF performance can offer a glimpse at current conditions, we dug deeper and analyzed recent biopharma index strength, IPO activity and follow-on offerings, among other metrics.

Our analysis indicates the market remains strong, albeit with some signs of moderation.

Continue Reading

Guide to Selecting a Winning IPO Team

Going public? Learn how to identify the right people to work with your company by downloading our latest eBook, Guide to Selecting a Winning IPO Team.

Our Locations